32nd International Papillomavirus Conference

Country: Australia

City: Sydney

Abstr. due: 17.04.2018

Dates: 02.10.18 — 06.10.18

Area Of Sciences: Biology;

Organizing comittee e-mail: http://ipvc2018.org/abstract-information/abstract-submission-2#.WntmG3yYO70

Organizers: Kenes Group


Join us for the 32nd International Papillomavirus Conference, to be held October 2-6 in Sydney, Australia! IPVC 2018 will gather researchers, clinicians and other health professionals to share knowledge and ideas on papillomaviruses and their associated diseases as we work towards global control of HPV disease. As with past IPVS conferences, IPVC 2018 will include an outstanding program of invited lectures, oral abstract sessions, poster sessions, symposia, workshops and social events. We look forward to seeing you in Sydney!​​​​​​​ 


Basic Research

  1. Taxonomy
  2. Animal models
  3. Immunology
  4. Regulation of gene expression
  5. Transformation and carcinogenesis
  6. Structural biology
  7. Virus - host interactions
  8. Virus life cycle
  9. Genomics of HPV-associated disease
  10. Papillomavirus vaccines (i.e. new developments)
  11. Other basic research

    Clinical Research

    1. HPV diagnostics and biomarkers I: HPV triage technologies
    2. HPV diagnostics and biomarkers II: Validation platforms (e.g. Valgent) 
    3. HPV diagnostics and biomarkers III: Quality and performance verification for clinical HPV tests 
    4. HPV self-collection 
    5. Diagnosis and management of cervical  cancer and its precursors
    6. Diagnosis and management of anal cancer and its precursors
    7. Diagnosis and management of penile, vulvar and vaginal  cancer and precursors
    8. Diagnosis and management of oropharyngeal, head and neck cancer
    9. Diagnosis and management of genital and skin warts
    10. Diagnosis and management of HPV associated skin lesions other than warts
    11. Prophylactic vaccines – clinical aspects
    12. Therapeutic vaccines – clinical aspects
    13. Management of HPV disease in HIV-infected people
    14. Treatment of precancer in low resource settings 
    15. Cochrane reviews of HPV vaccination and screening 
    16. Treatment of HPV-related disease
    17. Recurrent Respiratory Papillomatosis
    18. Other clinical research

      Public Health / Epidemiology

      1. Global impact of HPV and cervical cancer prevention 
      2. Epidemiology: natural history/global burden/risk factors
      3. Screening for HPV related disease: implementation, evaluation and impact
      4. Vaccine safety: new evidence and public perception
      5. Quality standards and methods for economics and mathematical modelling (e.g. HPV-FRAME) 
      6. Cancer control in Indigenous peoples. 
      7. Cancer control in Culturally And Linguistically Diverse Groups (CALD).

        High resource settings

        37.  Screening for HPV related disease: implementation, evaluation and impact
        38.  Vaccination: implementation, evaluation and impact
        39.  Economics and mathematical modelling in HIC 

        40.  Primary HPV vs co-testing with HPV and cytology 

        Low and middle income (LMIC) settings

        41.  Screening for HPV related disease screening: implementation, evaluation and               impact'
        42.  Scale up of HPV vaccination in Gavi-eligible countries
        43.  Cervical screening and combined screening vaccination strategies  in LMIC
        44.  Economics and mathematical modelling for LMIC 
        45.  Vaccine and screening implementation in non GAVI-eligible/middle income                 countries 
        46.  Psychosocial impact of new HPV and cervical cancer prevention strategies 
        47.  Other public health / epidemiology research   

        Conference Web-Site: http://ipvc2018.org/